TMEM37 and chronic myelogenous leukemia, BCR-ABL1 positive: A number of previous studies have implicated that PR1 (a peptide for proteinase-3) is an important tumor antigen for CTL immune response against CML and that specific anti-PR1 T-cells are involved in the elimination of CML cells [37], [38].